Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
501-1000
employees, estimated range
Backers
2
Canaan, SR One
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2024 Founded
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Draupnir BioSeed $13M · 2 yr ago
Draupnir Bio is developing new innovative therapies for patients.
We navigate evolutionary data to translate extreme biological adaptations into first-in-class medicines. Learn more about our process.
XYLO11-50 employees
Xylo is pioneering next-generation therapeutics designed to rewire neural circuits and restore brain function. Discover our innovative…
NeuraLight51-200 employees
Precision biomarkers that quantify functional brain change. Supporting drug development and brain health programs.
NovogaiaFounded 2024 • 1 role
Novogaia is an applied AI drug discovery company that builds machine learning systems to decode the chemistry of natural organisms…
Our goal is to streamline drug development in order to accelerate patient access to important medical therapies.

Overview

Transforming the Future of Neuropsychiatry. Draig Therapeutics is developing transformative, best-in-class neuropsychiatric therapies to restore the brain to a healthier state, enabling patients to live their best lives.